Phorbaketal A stimulates osteoblast differentiation through TAZ mediated Runx2 activation

FEBS Letters

Volumn 586, Issue 8, 2012, Pages 1086-1092

  Byun, Mi Ran ^a   Kim, A Rum ^a   Hwang, Jun Ha ^a   Sung, Mi Kyung ^a   Lee, Yeon Kyung ^a   Hwang, Buyng Su ^b   Rho, Jung Rae ^b   Hwang, Eun Sook ^c   Hong, Jeong Ho ^a  

^a Korea University   (South Korea)

^b Kunsan National University   (South Korea)

^c Ewha Womans University   (South Korea)

Author keywords

Differentiation; ERK; Osteoblast; Phorbaketal A; TAZ

Indexed keywords

BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; NATURAL PRODUCT; PHORBAKETAL A; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTIONAL COACTIVATOR WITH PDZ BINDING MOTIF; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL STIMULATION; CONTROLLED STUDY; DRUG ISOLATION; DRUG MECHANISM; ENZYME ACTIVATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; MARKER GENE; MESENCHYME CELL; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN INTERACTION; SPONGE (PORIFERA);

ANIMALS; CELL DIFFERENTIATION; CORE BINDING FACTOR ALPHA 1 SUBUNIT; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; MESENCHYMAL STEM CELLS; MICE; OSTEOBLASTS; SESTERTERPENES; TRANSCRIPTION FACTORS;

EID: 84862811661     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2012.03.008     Document Type: Article

References (27)

1. C. Deal Potential new drug targets for osteoporosis Nat. Clin. Pract. Rheumatol. 5 2009 20 27
2. R. Trivedi, A. Mithal, and N. Chattopadhyay Anabolics in osteoporosis: the emerging therapeutic tool Curr. Mol. Med. 10 2010 14 28
3. X. Yang, and G. Karsenty Transcription factors in bone: developmental and pathological aspects Trends Mol. Med. 8 2002 340 345 (Pubitemid 34733388)
4. K. Nakashima, and B. de Crombrugghe Transcriptional mechanisms in osteoblast differentiation and bone formation Trends Genet. 19 2003 458 466 (Pubitemid 36930029)
5. P. Ducy, R. Zhang, V. Geoffroy, A.L. Ridall, and G. Karsenty Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation Cell 89 1997 747 754 (Pubitemid 27516177)
6. T. Komori Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts Cell 89 1997 755 764 (Pubitemid 27516178)
7. T. Komori Regulation of skeletal development by the Runx family of transcription factors J. Cell Biochem. 95 2005 445 453 (Pubitemid 41420175)
8. J.H. Hong TAZ, a transcriptional modulator of mesenchymal stem cell differentiation Science 309 2005 1074 1078
9. W.M. Mahoney Jr., J.H. Hong, M.B. Yaffe, and I.K. Farrance The transcriptional co-activator TAZ interacts differentially with transcriptional enhancer factor-1 (TEF-1) family members Biochem. J. 388 2005 217 225 (Pubitemid 40732949)
10. S.W. Chan, C.J. Lim, L.S. Loo, Y.F. Chong, C. Huang, and W. Hong TEADs mediate nuclear retention of TAZ to promote oncogenic transformation J. Biol. Chem. 284 2009 14347 14358
11. H. Zhang TEAD transcription factors mediate the function of TAZ in cell growth and epithelial-mesenchymal transition J. Biol. Chem. 284 2009 13355 13362
12. K.S. Park, J.A. Whitsett, T. Di Palma, J.H. Hong, M.B. Yaffe, and M. Zannini TAZ interacts with TTF-1 and regulates expression of surfactant protein-C J. Biol. Chem. 279 2004 17384 17390 (Pubitemid 38560499)
13. M. Murakami, M. Nakagawa, E.N. Olson, and O. Nakagawa A WW domain protein TAZ is a critical coactivator for TBX5, a transcription factor implicated in Holt-Oram syndrome Proc. Natl. Acad. Sci. USA 102 2005 18034 18039 (Pubitemid 41798497)
14. M. Murakami, J. Tominaga, R. Makita, Y. Uchijima, Y. Kurihara, O. Nakagawa, T. Asano, and H. Kurihara Transcriptional activity of Pax3 is co-activated by TAZ Biochem. Biophys. Res. Commun. 339 2006 533 539 (Pubitemid 41739700)
15. X. Varelas TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal Nat. Cell Biol. 10 2008 837 848 (Pubitemid 351927712)
16. H. Jeong, S. Bae, S.Y. An, M.R. Byun, J.H. Hwang, M.B. Yaffe, J.H. Hong, and E.S. Hwang TAZ as a novel enhancer of MyoD-mediated myogenic differentiation FASEB J. 24 2010 3310 3320
17. C.Y. Liu The hippo tumor pathway promotes TAZ degradation by phosphorylating a phosphodegron and recruiting the SCF{beta}-TrCP E3 ligase J. Biol. Chem. 285 2010 37159 37169
18. Q.Y. Lei TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway Mol. Cell Biol. 28 2008 2426 2436
19. J.R. Rho, B.S. Hwang, C.J. Sim, S. Joung, H.Y. Lee, and H.J. Kim Phorbaketals A, B, and C, sesterterpenoids with a spiroketal of hydrobenzopyran moiety isolated from the marine sponge Phorbas sp Org. Lett. 11 2009 5590 5593
20. G. Xiao, D. Jiang, P. Thomas, M.D. Benson, K. Guan, G. Karsenty, and R.T. Franceschi MAPK pathways activate and phosphorylate the osteoblast-specific transcription factor, Cbfa1 J. Biol. Chem. 275 2000 4453 4459 (Pubitemid 30094689)
21. G. Xiao, D. Jiang, R. Gopalakrishnan, and R.T. Franceschi Fibroblast growth factor 2 induction of the osteocalcin gene requires MAPK activity and phosphorylation of the osteoblast transcription factor, Cbfa1/Runx2 J. Biol. Chem. 277 2002 36181 36187
22. J.L. Frendo, G. Xiao, S. Fuchs, R.T. Franceschi, G. Karsenty, and P. Ducy Functional hierarchy between two OSE2 elements in the control of osteocalcin gene expression in vivo J. Biol. Chem. 273 1998 30509 30516 (Pubitemid 28545526)
23. C. Ge, G. Xiao, D. Jiang, and R.T. Franceschi Critical role of the extracellular signal-regulated kinase-MAPK pathway in osteoblast differentiation and skeletal development J. Cell Biol. 176 2007 709 718 (Pubitemid 46333984)
24. O.J. Park, H.J. Kim, K.M. Woo, J.H. Baek, and H.M. Ryoo FGF2-activated ERK mitogen-activated protein kinase enhances Runx2 acetylation and stabilization J. Biol. Chem. 285 2010 3568 3574
25. T. Matsuguchi, N. Chiba, K. Bandow, K. Kakimoto, A. Masuda, and T. Ohnishi JNK activity is essential for Atf4 expression and late-stage osteoblast differentiation J. Bone Miner. Res. 24 2009 398 410
26. H. Liu, Y. Liu, M. Viggeswarapu, Z. Zheng, L. Titus, and S.D. Boden Activation of c-Jun NH(2)-terminal kinase 1 increases cellular responsiveness to BMP-2 and decreases binding of inhibitory Smad6 to the type 1 BMP receptor J. Bone Miner. Res. 26 2011 1122 1132
27. F. Kanai TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins EMBO J. 19 2000 6778 6791 (Pubitemid 32011671)